-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Thermo Fisher Scientific Prices $3.8B Offering Of Senior Notes Due 2031-2046 For Clario Acquisition And Corporate Purposes

Benzinga·02/10/2026 08:13:34
Listen to the news
  • $1.0 billion aggregate principal amount of its 4.215% senior notes due 2031 (the "2031 notes") at the issue price of 100.000% of their principal amount;
  • $750 million aggregate principal amount of its 4.550% senior notes due 2033 (the "2033 notes") at the issue price of 99.783% of their principal amount;
  • $1.3 billion aggregate principal amount of its 4.902% senior notes due 2036 (the "2036 notes") at the issue price of 100.000% of their principal amount; and
  • $750 million aggregate principal amount of its 5.546% senior notes due 2046 (the "2046 notes" and, together with the 2031 notes, the 2033 notes and the 2036 notes, the "notes") at the issue price of 100.000% of their principal amount.